Halberd's COVID-19 Antibody is the Only One In Competitive Tests to Bind to Omicron Variant

Outperforms Approved COVID AntibodiesJACKSON CENTER, PA / ACCESSWIRE / March 1, 2022 / Halberd Corporation's (OTC PINK:HALB) previously developed SARS-CoV-2 antibody demonstrated superior binding capability to the SARS-CoV-2 Omicron variant disease …